Gut Microbiota: Clinical Trials

5 trials for Gut Microbiota, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 not yet recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Unknown 2, Not yet recruiting 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow Gut Microbiota: new trials by email Literature Review of Gut Microbiota trials Research Report on Gut Microbiota

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM)
Phase 2Not yet recruitingZealand University Hospital1502027-03-012026-09-25
The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis
Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules - Radiation Proctitis, Probiotics
Phase 2 / Phase 3UnknownWest China Hospital1762022-04-152022-07-15
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
Pembrolizumab Combined With Chemotherapy - Gut Microbiota, NSCLC
Phase 1 / Phase 2UnknownXiaorong Dong402020-04-012020-04-03
The Change of Gut Microbiota After Bowel Preparation and the Effect of Probiotics
Duolac - Gut Microbiota, Bowel Preparation
Phase 2CompletedKosin University Gospel Hospital1002018-12-012020-02-20
Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota
Riboflavin Dose 1, Riboflavin Dose 2, Placebo - Gut Microbiota
Phase 2Completeddsm-firmenich Switzerland AG1052016-11-012020-01-22

Narrower conditions

Febrile Neutropenia (1)  ·  Multiple Myeloma (1)

Broader conditions

Agranulocytosis (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Cytopenia (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Ceftazidime (1)  ·  Ciprofloxacin (1)  ·  Drug Therapy (1)  ·  Riboflavin (1)

Sponsors

Kosin University Gospel Hospital (1)  ·  West China Hospital (1)  ·  Xiaorong Dong (1)  ·  Zealand University Hospital (1)  ·  dsm-firmenich Switzerland AG (1)

Countries

China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Hermie J.M. Harmsen, PhD (1)

Results publications

PMID 35943883